CTN Bulletin logo
June 7, 2019

Must-Watch Summer Movies!

SHARE ISSUE ON 

Facebook

Laptop with popcorn and sodaOkay, okay, they're actually must-watch summer webinars (sorry!), but what could be better than grabbing some popcorn on a hot day and tuning into an amazing, informative webinar on a topic that interests you, right?

COMING SOON

June 11, July 17, August 15
Stimulant Use Disorder Webinar Series
This 3-part series, sponsored by the Northwest and Great Lakes ATTCs, will cover the critical issues related to stimulant use. The first installment, on June 11, will be presented by Richard Rawson, PhD, and will address Strategies to Address Cocaine and Methamphetamine.

June 12
Prisoner Engagement in Clinical Trials-- Sarah Farkas, MA, Dagmar Salazar MS, Amber Regis, BA, Peter Greco, MPH. Learn how to prepare prior to the start of a study and coordinate procedures during it to effectively locate and retain participants lost to incarceration.

June 26
Medications for Opioid Use Disorder and Hepatitis C: Access and Adherence Among Persons Who Inject Drugs -- Judith Tsui, MD, MPH
Hosted by the Northwest ATTC and the Area Health Education Center for Western Washington, this webinar will describe research on innovative models of care to improve treatment access and outcomes for persons with OUD and HCV. 1 CME available.

ON DEMAND/ANYTIME

CTN Northeast Node's "Science Series." The Northeast node sponsors an academic bimonthly series on the state of the science on addiction. Find the archive of recorded webinars here! The next live webinar will be held on September 12, 2009 and will feature Jennifer McNeely, PhD talking about "Screening for Substance Use in Primary Care."

CTN Clinical Coordinating Center Webinar Series. Bet you've missed a few CTN CCC webinars over the years. This is a great time to catch up! Find the complete archives in the CTN Dissemination Library!

NAADAC Institute Webinar Series. NAADAC, an organization for addiction practitioners and providers, has a ton of webinars you can watch any time for CE credits (credits are free for NAADAC members and inexpensive for others). Topics from 2019 so far have included adolescent nicotine use, addressing the opioid crisis via community-based technical assistance, implementing SBIRT in rural clinics, and more.

CTN Trial Progress

GraphRandomizations for Active Studies as of the June 6 trial Progress Report.

CTN-0067 - CHOICES Scale-Up. Enrolled 116

CTN-0068 - ADAPT-2 for Methamphetamine Use Disorder. Enrolled 403

CTN-0069 - OUD in the Emergency Department. Enrolled 507

CTN-0075 - Physician-Pharmacist Collaboration - OUD
Enrolled 76

CTN-0079 - ED-CONNECT
Enrolled 47

Total randomizations in active trials: 1149

 

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.


· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

News from the Nodes

Northeast Node

Northeast NodeOn May 23rd the Northeast Node hosted Joshua D. Lee, MD, MSc, Associate Professor at the NYU School of Medicine and Director of the NYU Fellowship in Addiction Medicine and affiliate of the Greater New York Node, as part of their Science Series.

Dr. Lee presented on "Opioid Pharmacotherapies for Primary Care and Criminal Justice Populations: Low Threshold, Low Barrier Approaches to Naltrexone and Buprenorphine Treatments."

These "low threshold" models for medication treatment value broad inclusion criteria, minimal additional mandates for counseling, immediate and sustained access to medications, and regular but not intensive follow-up to support medication adherence and positive clinical outcomes.

To get an overview of opioid treatments in primary care and criminal justice populations and learn more about the clinical trials that Dr. Lee has conducted in this area, you may access his full presentation on the Northeast Node’s website.

In other news, the NIDA T-32 Science of Co-Occurring Disorders Postdoctoral Training Program, led by Northeast Node faculty affiliate Alan Budney, PhD at Dartmouth College, is welcoming post-doctoral fellow applicants.

This is a unique transdisciplinary/translational research program focused on co-occurring substance use and other mental or physical disorders offered through the Geisel School of Medicine at Dartmouth.

During the typical 2-3 year-long appointments, postdoctoral fellows will be provided with research opportunities in intervention research under the mentorship of faculty that are experts in their fields and leading diverse projects funded by NIH and other federal institutes.

To be eligible, applicants must have completed their training in psychology, or a related discipline and be U.S. citizens or permanent residents.

Trainees are selected on the basis of scholastic record and commitment to a career in research related to addiction and mental health. Benefits include a stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards.

To apply, applicants should forward their curriculum vitae, statement of research interests, and 3 letters of reference to Brian Goodness. Contact Dr. Budney, or Dr. Stanger for more information.

You can follow the Northeast Node on Twitter and Facebook.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

New England Consortium

Northeast NodeIn the June 2019 issue of the Monitor on Psychology from the American Psychological Association (APA), a special report reviewed solutions for the opioid crisis.

Kathleen Carroll, PhD and R. Kathryn McHugh, PhD from the New England Consortium Node were quoted in the article and research publications resulting from the Clinical Trials Network were cited in the article, including the review article on the role of behavioral treatment interventions in Buprenorphine Maintenance Treatment by Drs. Carroll and Weiss in the American Journal of Psychiatry, Volume 174, Issue No. 8, 2017, as well as the work on CBT4CBT conducted by Dr. Carroll.

Find the article here.

 



Western States

Northeast NodeNode Co-PI James Sorensen Receives Fulbright Fellowship

James Sorensen, PhD, one of the co-PIs of the Western States Node, has been awarded a Fulbright fellowship for international study. Dr. Sorensen, a Professor of Psychiatry at UCSF, was award a Fulbright Canada Research Chair in Child and Youth Mental Health at the University of Calgary, for his project entitled, "Linking Addiction Treatments and Research: Focus on Ethics."

Dr. Sorensen is spending four months at University of Calgary, in Calgary, Alberta accomplishing three objectives:

  1. Become more familiar with how addiction policies are implemented at a local level;
  2. Collaborate with colleagues, mutually sharing approaches; and
  3. Identify ethical dilemmas facing line staff that can be addressed more effectively in addiction research and training.

Find out more about the Fulbright program here!

Postdoc Training Program Renewed

UCSF logoUCSF is one of the two Regional Research & Training Centers (RRTCs) for the Western States Node of the NIDA Clinical Trials Network. Their postdoctoral training program, entering its 26th year, develops substance use disorders (SUD) treatment and services researchers.

The training focuses on clinical trials of behavioral, pharmacological and psychosocial interventions; services research, including organizational change, in health care systems; psychosocial and biological factors that interact with treatments, including genetics and neuroimaging; and, treatment and services research in complex, comorbid populations.

To date, the program has successfully trained 60 doctoral level psychologists, physicians, public health, and policy professionals for academic and research careers.

The core faculty members have strong histories of mentorship, extensive experience in obtaining extramural funding, and ongoing research productivity in SUD treatment and services research. In early 2019, the UCSF postdoctoral training program received a renewal for another five years.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

From the ATTC & SAMHSA

ATTC logo ATTC Messenger, June 2019 -
Re-Emergence of Cocaine and Methamphetamine Use in the 21st Center
Richard Rawson, PhD

ATTC/NIATx Service Improvement Blog
The South Southwest ATTC Consortium of Higher Education Institutions - Maureen Nichols, Director South Southwest ATTC

New Online Opioid Training for Peers
ATTC logoSupporting Recovery from Opioid Use: A Peer's Guide to Person-Centered Care
This free, one-hour, interactive online training is designed to equip peer support specialists and other outreach workers with information, resources, and practical tips to help them better understand opioids and their impact on individuals. 1 CEU available.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

NIDA-Sponsored Learning for Early Careers in Addiction & Diversity (LEAD) Program Renewed for 5 Years

ATTC/WSN Logo The Learning for Early Careers in Addiction and Diversity (LEAD) Program is a research education program that provides training to early-stage research scientists from underrepresented racial/ethnic minority groups. The LEAD Program aims to increase the number of racial/ethnic minorities who conduct behavioral or pharmacological substance use disorders treatment research.

The training program utilizes its strong connections to faculty conducting clinical research at UCSF and builds on the platform of the NIDA Clinical Trials Network.

LEAD Scholars are matched with senior scientists in the CTN and faculty members at UCSF who will provide scientific mentoring and professional guidance to their scholar mentee. Over the course of three years, scholars conduct pilot research as a pathway to subsequent NIH applications; cultivate their grant-writing skills with the goal of submitting competitive NIH applications; participate in workshops relating to the cultural tailoring of evidence-based treatments and implementation research methods; and foster connections with leading experts in substance use disorder clinical trials research.

Since its inception in 2014, the LEAD Program has graduated nine research scientists. To date, six scholars (67%) of nine have submitted proposals to NIH, four scholars (44%) have received K awards, and two scholars (22%) have received R awards as PI or co-PI. Five scholars are currently participating in the program.

In early 2019, the LEAD Program received a renewal for another five years. The Program has focused on expanding the scope of implementation science training to align with the CTN and the overall priorities of NIDA.

For more about the LEAD Program, visit https://psych.ucsf.edu/lead

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

New in the CTN Dissemination Library

journal coversMedication adherence monitoring using smartphone video dosing in an open-label pilot study of monthly naltrexone plus once-daily bupropion for methamphetamine use disorder: Feasibility and acceptability. Walker NR, et al. Journal of Addiction Medicine 2019 (in press).

A quality framework for emergency department treatment of opioid use disorder. Samuels EA, et al. Annals of Emergency Medicine 2019;73:237.247.

Interpretation and integration of the federal substance use privacy protection rule in integrated health systems: A qualitative analysis. Campbell ANC, et al. Journal of Substance Abuse Treatment 2019;97:41-46.

Acute and long-term cannabis use among stimulant users: Results from CTN-0037 STimulant Reduction Intervention using Dosed Exercise (STRIDE) randomized trial. Vidot DC, et al. Drug and Alcohol Dependence 2019 (in press).

Also of Interest

AHSR logo2019 Addiction Health Services Research Conference, October 16-18, 2019: Have you made your plans for AHSR yet? Get started here!

SMI logoSMI Adviser: This new platform from SAMHSA and the American Psychiatric Association (APA) provides a clinical support system for providers who care for people with serious mental illness. Find evidence-based data that supports your care planning and helps you make treatment decisions. Check it out here.

NIDA logo14 Year-Old Awarded 2019 NIDA Addiction Science Award: High school freshman Aditya Tummala from South Dakota won the first place distinction for this year's Addiction Science awards for his project related to a novel technology to prevent opioid tampering. Find out more about Aditya and the 2nd and 3rd place winners here!

     

Published by the CTN Dissemination Library of the Pacific Northwest Node
Alcohol & Drug Abuse Institute, University of Washington

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol & Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.

Unsubscribe | Subscribe